• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病与失眠:一项文献计量学研究及可视化分析

Alzheimer's disease and insomnia: a bibliometric study and visualization analysis.

作者信息

Tian Zi-Yue, Jiang Bing, Jin Meng, Yu Xiao-Kun, Chen Qi-Lin, Wang Jia-Hui

机构信息

Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.

Department of Integrated Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.

出版信息

Front Aging Neurosci. 2025 Apr 8;17:1542607. doi: 10.3389/fnagi.2025.1542607. eCollection 2025.

DOI:10.3389/fnagi.2025.1542607
PMID:40264463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12011777/
Abstract

BACKGROUND

Alzheimer's disease (AD) is the fastest-growing neurodegenerative disorder globally, with patient numbers expected to rise to 130 million by 2050. Insomnia, a prevalent comorbidity, exhibits a bidirectional relationship with AD: insomnia accelerates AD pathology, while AD worsens sleep disorders. This relationship has emerged as a key area of research. Current mechanisms involve oxidative stress, inflammatory responses, and glymphatic system dysfunction, yet a comprehensive review of these processes remains absent.

OBJECTIVE

To conduct a visual analysis of the relationship between Alzheimer's disease and insomnia using CiteSpace.

METHODS

Literature on "insomnia" and "Alzheimer's disease" published between January 1, 2000, and October 31, 2024, was retrieved from the Web of Science Core Collection. CiteSpace and VOSviewer software were used to analyze institutions, authors, and keywords.

RESULTS

A total of 1,907 articles were analyzed, revealing a consistent upward trend in publication volume. The United States and the Mayo Clinic were identified as leading contributors, producing 704 and 57 publications, respectively. Boeve Bradley F the most prolific author contributed 30 publications. Collaboration was actively observed among countries, institutions, and authors. High-frequency keywords identified were "Parkinson's disease," "cognitive impairment," and "sleep behavior disorder." Emerging research areas are likely to focus on "sleep quality" and the "glymphatic system."

CONCLUSION

This study is the first to apply bibliometric analysis to identify three key trends in AD and insomnia research: the dominance of the United States and Mayo Clinic, strong international collaboration, and a focus on critical areas such as cognitive impairment, the glymphatic system, and sleep interventions. Insomnia may accelerate AD progression via multiple pathways, indicating that enhancing sleep quality could provide new strategies for early intervention. Future research should prioritize advancing the clinical translation of sleep interventions and investigating the mechanisms of the glymphatic system.

摘要

背景

阿尔茨海默病(AD)是全球增长最快的神经退行性疾病,预计到2050年患者数量将增至1.3亿。失眠是一种常见的共病,与AD呈现双向关系:失眠加速AD病理进程,而AD则使睡眠障碍恶化。这种关系已成为一个关键研究领域。目前的机制涉及氧化应激、炎症反应和脑淋巴系统功能障碍,但对这些过程仍缺乏全面综述。

目的

使用CiteSpace对阿尔茨海默病与失眠之间的关系进行可视化分析。

方法

从Web of Science核心合集中检索2000年1月1日至2024年10月31日发表的关于“失眠”和“阿尔茨海默病”的文献。使用CiteSpace和VOSviewer软件分析机构、作者和关键词。

结果

共分析了1907篇文章,显示出发表量持续上升的趋势。美国和梅奥诊所被确定为主要贡献者,分别发表了704篇和57篇文章。发文最多的作者Boeve Bradley F发表了30篇文章。观察到国家、机构和作者之间积极开展合作。识别出的高频关键词有“帕金森病”“认知障碍”和“睡眠行为障碍”。新兴研究领域可能集中在“睡眠质量”和“脑淋巴系统”。

结论

本研究首次应用文献计量分析确定了AD与失眠研究的三个关键趋势:美国和梅奥诊所的主导地位、强大的国际合作以及对认知障碍、脑淋巴系统和睡眠干预等关键领域的关注。失眠可能通过多种途径加速AD进展,这表明提高睡眠质量可为早期干预提供新策略。未来研究应优先推进睡眠干预的临床转化并研究脑淋巴系统的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/c2616e703c58/fnagi-17-1542607-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/f416b660a134/fnagi-17-1542607-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/4267a1cf6369/fnagi-17-1542607-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/3a4201ec8d89/fnagi-17-1542607-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/748adde5bc20/fnagi-17-1542607-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/ec3ee063a10f/fnagi-17-1542607-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/36e9e3ef6f99/fnagi-17-1542607-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/acff8b363642/fnagi-17-1542607-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/e46613792460/fnagi-17-1542607-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/5bfed852a050/fnagi-17-1542607-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/c2616e703c58/fnagi-17-1542607-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/f416b660a134/fnagi-17-1542607-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/4267a1cf6369/fnagi-17-1542607-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/3a4201ec8d89/fnagi-17-1542607-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/748adde5bc20/fnagi-17-1542607-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/ec3ee063a10f/fnagi-17-1542607-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/36e9e3ef6f99/fnagi-17-1542607-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/acff8b363642/fnagi-17-1542607-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/e46613792460/fnagi-17-1542607-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/5bfed852a050/fnagi-17-1542607-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/12011777/c2616e703c58/fnagi-17-1542607-g0010.jpg

相似文献

1
Alzheimer's disease and insomnia: a bibliometric study and visualization analysis.阿尔茨海默病与失眠:一项文献计量学研究及可视化分析
Front Aging Neurosci. 2025 Apr 8;17:1542607. doi: 10.3389/fnagi.2025.1542607. eCollection 2025.
2
An examination of Alzheimer's disease and white matter from 1981 to 2023: a Bibliometric and visual analysis.1981年至2023年阿尔茨海默病与白质研究:文献计量学与可视化分析
Front Neurol. 2023 Nov 14;14:1268566. doi: 10.3389/fneur.2023.1268566. eCollection 2023.
3
Application of artificial intelligence in Alzheimer's disease: a bibliometric analysis.人工智能在阿尔茨海默病中的应用:一项文献计量分析
Front Neurosci. 2025 Feb 14;19:1511350. doi: 10.3389/fnins.2025.1511350. eCollection 2025.
4
Trends of mitochondrial changes in AD: a bibliometric study.阿尔茨海默病中线粒体变化的趋势:一项文献计量学研究。
Front Aging Neurosci. 2023 May 16;15:1136400. doi: 10.3389/fnagi.2023.1136400. eCollection 2023.
5
Key developments and hotspots of exosomes in Alzheimer's disease: a bibliometric study spanning 2003 to 2023.阿尔茨海默病中外泌体的关键进展与热点:一项涵盖2003年至2023年的文献计量学研究
Front Aging Neurosci. 2024 May 1;16:1377672. doi: 10.3389/fnagi.2024.1377672. eCollection 2024.
6
Knowledge Structure and Emerging Trends of Mild Cognitive Impairment with Dyssomnias in Recent 20 Years: A Bibliometric Analysis via CiteSpace and VOSviewer.近 20 年来失眠相关轻度认知障碍的知识结构和新兴趋势:基于 CiteSpace 和 VOSviewer 的文献计量分析。
Behav Neurol. 2024 Jan 6;2024:6622212. doi: 10.1155/2024/6622212. eCollection 2024.
7
Association between Sleep and Alzheimer's Disease: A Bibliometric Analysis from 2003 to 2022.睡眠与阿尔茨海默病的关联:2003 年至 2022 年的文献计量分析。
Neuroepidemiology. 2023;57(6):377-390. doi: 10.1159/000533700. Epub 2023 Sep 12.
8
Global trend of nondrug and nonsedativehypnotic treatment forinsomnia: a bibliometric study.全球非药物和非镇静催眠药物治疗失眠的趋势:一项文献计量学研究。
J Tradit Chin Med. 2024 Jun;44(3):595-608. doi: 10.19852/j.cnki.jtcm.20240408.002.
9
Mapping Research Trends and Hotspots in the Link between Alzheimer's Disease and Gut Microbes over the Past Decade: A Bibliometric Analysis.绘制过去十年阿尔茨海默病与肠道微生物关系的研究趋势和热点的图谱:文献计量分析。
Nutrients. 2023 Jul 19;15(14):3203. doi: 10.3390/nu15143203.
10
Research Trends and Visualization of Cerebrospinal Fluid Dynamics (2013-2023).脑脊液动力学的研究趋势与可视化(2013 - 2023年)
World Neurosurg. 2024 Nov;191:254-266.e6. doi: 10.1016/j.wneu.2024.08.085. Epub 2024 Aug 22.

本文引用的文献

1
Influencing factors of glymphatic system during perioperative period.围手术期糖淋巴系统的影响因素。
Front Neurosci. 2024 Sep 12;18:1428085. doi: 10.3389/fnins.2024.1428085. eCollection 2024.
2
Multisensory gamma stimulation promotes glymphatic clearance of amyloid.多觉γ刺激促进淀粉样蛋白的神经胶质淋巴清除。
Nature. 2024 Mar;627(8002):149-156. doi: 10.1038/s41586-024-07132-6. Epub 2024 Feb 28.
3
Epigenetic Regulation of Neuroinflammation in Alzheimer's Disease.阿尔茨海默病中神经炎症的表观遗传调控。
Cells. 2023 Dec 29;13(1):79. doi: 10.3390/cells13010079.
4
The effect of light therapy on sleep disorders and psychobehavioral symptoms in patients with Alzheimer's disease: A meta-analysis.光照疗法对阿尔茨海默病患者睡眠障碍和精神行为症状的影响:一项荟萃分析。
PLoS One. 2023 Dec 6;18(12):e0293977. doi: 10.1371/journal.pone.0293977. eCollection 2023.
5
Causal relationship between Alzheimer's disease and cardiovascular disease: a bidirectional Mendelian randomization analysis.阿尔茨海默病与心血管疾病之间的因果关系:双向孟德尔随机化分析。
Aging (Albany NY). 2023 Sep 2;15(17):9022-9040. doi: 10.18632/aging.205013.
6
Tau-PET abnormality as a biomarker for Alzheimer's disease staging and early detection: a topological perspective.Tau-PET 异常作为阿尔茨海默病分期和早期检测的生物标志物:拓扑学视角。
Cereb Cortex. 2023 Oct 9;33(20):10649-10659. doi: 10.1093/cercor/bhad312.
7
Circadian rhythm alterations affecting the pathology of neurodegenerative diseases.影响神经退行性疾病病理学的昼夜节律改变。
J Neurochem. 2024 Aug;168(8):1475-1489. doi: 10.1111/jnc.15883. Epub 2023 Jun 26.
8
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer's disease.阿尔茨海默病睡眠障碍的药物和非药物治疗选择。
Expert Rev Neurother. 2023 Jun;23(6):501-514. doi: 10.1080/14737175.2023.2214316. Epub 2023 Jun 2.
9
Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort Study.轻度认知障碍或痴呆个体中淀粉样蛋白PET阳性的种族和民族差异:淀粉样蛋白扫描成像痴呆证据(IDEAS)队列研究的二次分析
JAMA Neurol. 2022 Oct 3;79(11):1139-47. doi: 10.1001/jamaneurol.2022.3157.
10
The Role of Glymphatic System in Alzheimer's and Parkinson's Disease Pathogenesis.类淋巴系统在阿尔茨海默病和帕金森病发病机制中的作用。
Biomedicines. 2022 Sep 13;10(9):2261. doi: 10.3390/biomedicines10092261.